BioPharma Dive1d
Epicrispr banks $68M to test epigenetic editing on rare muscle disease
The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a disorder on the radars of several drugmakers.
Frontiers13h
Exploring Neuroprotective Mechanisms: From Molecular Pathways to Translational Strategies
Research on neuroprotective mechanisms aims to understand how the nervous system is protected from injury or degeneration. These studies commonly use animal ...
C&EN1d
Fluorinated Ribonucleocarbohydrate Nanoparticles Allow Ultraefficient mRNA Delivery and Protein Expression in Tumor-Associated Myeloid Cells
Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN, 5206, Boston, Massachusetts 02114, United States Department of Pathology, Massachusetts General Hospital, 55 ...
politicsweb2d
Jon Qwelane: Section 10 of PEPUDA goes beyond constitutional bounds - FXI
The Freedom of Expression Institute is due to present argument this afternoon. In defence of free expression, the FXI made its original application to be admitted as amicus curiae (friend of the court ...